AGEN
Price
$3.31
Change
-$0.04 (-1.19%)
Updated
Dec 26 closing price
Capitalization
112.57M
Intraday BUY SELL Signals
MRVI
Price
$3.27
Change
-$0.03 (-0.91%)
Updated
Dec 26 closing price
Capitalization
474.22M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AGEN vs MRVI

Header iconAGEN vs MRVI Comparison
Open Charts AGEN vs MRVIBanner chart's image
Agenus
Price$3.31
Change-$0.04 (-1.19%)
Volume$733.45K
Capitalization112.57M
Maravai LifeSciences Holdings
Price$3.27
Change-$0.03 (-0.91%)
Volume$1.76M
Capitalization474.22M
AGEN vs MRVI Comparison Chart in %
View a ticker or compare two or three
VS
AGEN vs. MRVI commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and MRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (AGEN: $3.31 vs. MRVI: $3.27)
Brand notoriety: AGEN and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 137% vs. MRVI: 126%
Market capitalization -- AGEN: $112.57M vs. MRVI: $474.22M
AGEN [@Biotechnology] is valued at $112.57M. MRVI’s [@Biotechnology] market capitalization is $474.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 7 bearish.
  • MRVI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а -3.78% price change this week, while MRVI (@Biotechnology) price change was -4.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

MRVI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($474M) has a higher market cap than AGEN($113M). AGEN YTD gains are higher at: 20.803 vs. MRVI (-40.000). AGEN has higher annual earnings (EBITDA): 33.3M vs. MRVI (-126.07M). MRVI has more cash in the bank: 244M vs. AGEN (3.46M). AGEN has less debt than MRVI: AGEN (45.8M) vs MRVI (368M). MRVI has higher revenues than AGEN: MRVI (192M) vs AGEN (107M).
AGENMRVIAGEN / MRVI
Capitalization113M474M24%
EBITDA33.3M-126.07M-26%
Gain YTD20.803-40.000-52%
P/E Ratio0.16N/A-
Revenue107M192M56%
Total Cash3.46M244M1%
Total Debt45.8M368M12%
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENMRVI
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 30 days ago
85%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signal:
Gain/Loss:
MRVI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GOIGX34.940.12
+0.34%
JHancock International Growth A
RIVRX28.230.03
+0.11%
Riverbridge Growth Investor
IRLNX87.750.01
+0.01%
Voya Russell Large Cap Growth Idx Port I
PRNIX29.24-0.02
-0.07%
Virtus NFJ Mid-Cap Value Inst
CMCMX9.41-0.05
-0.53%
Conestoga Discovery Investors

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-1.19%
TAOX - AGEN
91%
Closely correlated
-6.74%
PALI - AGEN
81%
Closely correlated
-2.27%
AXON - AGEN
42%
Loosely correlated
-1.24%
CLDX - AGEN
39%
Loosely correlated
-1.60%
MRVI - AGEN
38%
Loosely correlated
-0.91%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with TECH. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
-0.91%
TECH - MRVI
47%
Loosely correlated
+0.05%
CLDX - MRVI
41%
Loosely correlated
-1.60%
MRNA - MRVI
41%
Loosely correlated
-4.73%
AGEN - MRVI
38%
Loosely correlated
-1.19%
FENC - MRVI
38%
Loosely correlated
+5.48%
More